We are searching data for your request:
Upon completion, a link will appear to access the found materials.
Pharmaceutical companies active against cannabis legalization
A few months ago, a German court ruled that some seriously ill can legally grow hemp. In the United States, cannabis use is approved for medical use in several states. But there are also many opponents of legalizing marijuana everywhere. These include pharmaceutical companies.
Pain-relieving and anti-inflammatory In Germany, cannabis has also been used as a medicine for a long time. Its effectiveness has been proven, among other things, for nausea and vomiting or for cachexia, a disease in which extreme weight loss leads to extreme underweight. Experts also recommend marijuana or hashish if you have no appetite. Cannabis has an analgesic and anti-inflammatory effect and can help seriously ill people to better endure their suffering. This also applies to German patients who were allowed to grow hemp for their own use a few months ago by the Cologne Administrative Court. Men who are struggling with chronic pain, multiple sclerosis (MS) or attention deficit disorder, ADHD, claim that the drug is used to alleviate the pain.
Pharmaceutical companies fund organizations against cannabis legalization In the United States, cannabis use is approved for medical use in several states. Since this year, weeding has been legal in Washington and Colorado, as the "Focus" reports. However, there are indications that the pharmaceutical industry in the United States is trying to prevent legalization because it fears that its painkillers will be sold. The US magazine "The Nation" reports online that the "Community Anti-Drug Coalition of America" (CADCA) and "Partnership for Drug-Free Kinds" receive a considerable proportion of their budget from opiate manufacturers and other pharmaceutical companies. According to the information, the two organizations are campaigning against all forms of cannabis legalization. Critics accuse them of being very reluctant to fight dependency on prescription opiates.
Pharmaceutical industry barely interested in research It is said that "The Nation" has a confidential document that shows that the largest sponsors of the "Partnership for Drug-Free Kids" are the opiate manufacturers Purdue Pharma and Abott Laboratories. And according to the report, the CADCA receives money from the drug manufacturers Purdue Pharma, Alkermes, Janssen Pharmaceutical and Pfizer. Although the positive effects of marijuana have been proven in various studies, the pharmaceutical lobby apparently does not consider further investigations to be so important in this country either. The "Süddeutsche Zeitung" wrote in an article from September 2013: "The pharmaceutical industry, on the other hand, has little interest in research because the plant ingredients are hardly patentable." (Ad)